MEC Plus Full List View

MEC Plus

Myelodysplastic Syndromes and Acute Myeloid Leukemia
Myelodysplastic Syndromes and Acute Myeloid Leukemia
Kevin Kelly - MD - PhD
How I Treat Acute Myeloid Leukemia
How I Treat Acute Myeloid Leukemia
Brian A Jonas - MD - PhD - FACP
Small Cell Lung Cancer: Novel Approaches 2019
Small Cell Lung Cancer: Novel Approaches 2019
David R. Gandara - MD
Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical Trials
Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical Trials
Paul Frankel - PhD
New Developments in Cancer Research Hepatocellular and Biliary Cancers
New Developments in Cancer Research Hepatocellular and Biliary Cancers
Anthony El-Khoueiry - MD
Combination Radiation and Immunotherapy
Combination Radiation and Immunotherapy
Megan E Daly - MD
New Directions in the Management of Ovarian Cancer
New Directions in the Management of Ovarian Cancer
Mihaela Cristea - MD
Nasopharyngeal Carcinoma (NPC) 2019
Nasopharyngeal Carcinoma (NPC) 2019
A Dimitrios Colevas - MD
Esophageal and Gastric Cancer: New Developments
Esophageal and Gastric Cancer: New Developments
May Cho - MD
Updates in Hormone-Receptor Positive Breast Cancer
Updates in Hormone-Receptor Positive Breast Cancer
Helen K Chew - MD
Soft Tissue Sarcomas
Soft Tissue Sarcomas
Nam Bui - MD
Phase I Trials: Whats New in 2019?
Phase I Trials: Whats New in 2019?
Nam Bui - MD
Triple Negative Breast Cancer/BRCA Mutated Breast Cancer: What's New?
Triple Negative Breast Cancer/BRCA Mutated Breast Cancer: What's New?
Mili Arora - MD
CAR-T Cells and Other Cell Based Therapies
CAR-T Cells and Other Cell Based Therapies
Mehrdad Abedi - MD
Handling Common Toxicities of Immune Checkpoint Inhibitors
Handling Common Toxicities of Immune Checkpoint Inhibitors
Laura J Zitella - MS - RN - ACNP-BC - AOCN
Squamous Cell Carcinoma of the Lung: Finally Some Progress
Squamous Cell Carcinoma of the Lung: Finally Some Progress
Antoinette J Wozniak - MD - FASCO - FACP
ER/PR Breast Disease: Early Stage- Locally Advanced and Metastatic Breast Cancer
ER/PR Breast Disease: Early Stage- Locally Advanced and Metastatic Breast Cancer
Vicente Valero - MD - FACP
De Novo Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia
Martin S Tallman - MD
B-Cell NHL and Hodgkin’s Disease
B-Cell NHL and Hodgkin’s Disease
Eduardo Sotomayor - MD
RET- MET- and NTRK in Non-Small Cell Lung Cancer
RET- MET- and NTRK in Non-Small Cell Lung Cancer
Edgardo S Santos - MD - FACP
CLL: At Recurrence- What is the Best Therapy and What is Coming from the Bench Lab?
CLL: At Recurrence- What is the Best Therapy and What is Coming from the Bench Lab?
Saba S Nakhle - MD
The Entire Sepctrum of Her-2 Management in Breast Cancer Disease: All Clinical Settings
The Entire Sepctrum of Her-2 Management in Breast Cancer Disease: All Clinical Settings
Hope S Rugo - MD
Managing Expectations: Goals of Care
Managing Expectations: Goals of Care
Robin B Rome - FNP-ACHPN
The Role of Liquid Biopsy in Cancer Care: The Revolution
The Role of Liquid Biopsy in Cancer Care: The Revolution
Christian Rolfo - MD - PhD - MBA - Dr.h.c.
Upper GI Malignancies: Updates
Upper GI Malignancies: Updates
Thomas Reske - MD - PhD - CMD - FACP - AGFS
Therapeutic Developments For Neuroendocrine Tumors of the GI Tract and Others
Therapeutic Developments For Neuroendocrine Tumors of the GI Tract and Others
Robert Ramirez - DO - FACP
Challenges in Immunotherapy in NSCLC
Challenges in Immunotherapy in NSCLC
Luis E Raez - MD - FACP - FCCP
Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)
Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)
Terri Pollack - BA - DNP - MSN - APRN - FNP-C
CLL: How Do You Decide the Best Frontline Therapy?
CLL: How Do You Decide the Best Frontline Therapy?
Javier Pinilla-Ibarz - MD - PhD